We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Middle East IVF Market Driven by High Demand for IVF and Related Treatments

By LabMedica International staff writers
Posted on 23 Jan 2019
The global In Vitro Fertilization (IVF) market is currently estimated to be worth between USD 10 billion to USD 12 billion, while the IVF market in Middle East & North Africa (MENA) is estimated to be approximately USD 1 billion, indicating a high demand for IVF and related treatments in the region. More...


These are the findings in a new report published by Colliers International (Toronto, Canada) as part of the MEDLAB Market Report series ahead of MEDLAB 2019, which took place from February 4-7, 2019, at the Dubai World Trade Centre. MEDLAB Exhibition & Congress 2019, which is organized by Informa Exhibitions, welcomed more than 19,600 medical laboratory trade professionals and 670+ exhibitors from 46 countries in an effort to develop the value of laboratory medicine in shaping the future of healthcare and to provide advanced medical laboratory techniques for better health.

According to the latest report by Colliers International, the population in MENA has increased from over 100 million in 1950 to 380 million in 2017 and is expected to increase to 700 million by 2050, although the overall fertility rates in the region have decreased from seven children per women in 1960 to just three in 2017. Infertility in the MENA region is 15% or higher, as compared to 10% worldwide, with male infertility being a growing problem and occurring in approximately 50% of the cases in the GCC and Middle East. This can be attributed to lifestyle, diabetes, obesity and genetics related factors, as GCC countries have one of the highest diabetic and obesity rates in the world.

However, new innovations and improved testing techniques are gradually creating paradigm shifts in the field of assisted reproductive technology. In particular, increased focus on pre-marital screening for consanguineous (relatives) couples and development of new genetic tests for screening of embryos greatly improves the chance of minimizing certain genetic diseases common in this region.

“The Carrier Genetic Test (CGT) helps to determine the risk of having a child with a genetic disease. Anyone, without knowing, can be a carrier of one or more recessive mutations, but some couples have higher possibilities to carry the same genes,” said Dr. Laura Melado, Specialist – Obstetrics & Gynecology, IVF, IVI Middle East Fertility Clinic, Abu Dhabi, UAE, who will be speaking at the Cytogenetics & IVF Conference during MEDLAB 2019, commented. “When this happens Pre-implantation Genetic Testing (PGD) can be done for the embryos as part of the fertility treatment to help the couples to deliver healthy babies.”

“IVF is not only sought after locally but is one of the leading treatments undertaken by medical tourists in the UAE, especially in Dubai. Based on Colliers’ discussions with leading operators, medical tourism accounts for 10% to 15% of the IVF patient volumes,” said Mansoor Ahmed, Director Healthcare, Education & PPP for MENA Region at Colliers International.

Related Links:
Colliers International


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
Alcohol Testing Device
Dräger Alcotest 7000
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.